ClinicalTrials.govpublic full text
Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects
hiv infection, nk-1r antagonists, aprepitant, ritonavir boosting, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 867976
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.